HYBRID EVENT: You can participate in person at Singapore or Virtually from your home or work.
2nd Edition of International Cancer Research Conference
March 19-21, 2026 | Singapore
Case Reports
Case Reports
- Rare and Challenging Cases: Presentations of rare cancers and unusual clinical presentations.
- Innovative Treatments: Case studies of novel therapeutic approaches.
- Multi-disciplinary Case Management: Integrative approaches involving multiple specialties.
- Long-Term Survivorship Cases: Experiences and outcomes of long-term cancer survivors.
- Adverse Events and Complications: Managing unexpected treatment complications.
Case reports are essential in cancer research, providing in-depth analysis of uncommon or exceptional cases of cancer diagnosis, treatment, and progression. They offer unique insights that can inspire new treatment protocols, diagnostic techniques, and a better understanding of the disease’s behavior. By highlighting individual patient experiences, case reports help identify rare responses to therapies, unexpected side effects, or emerging patterns that might not be captured in large-scale studies. These reports are particularly valuable in oncology, as they enrich the scientific community’s knowledge and pave the way for future research and innovations in cancer care.
Committee Members
Rajvir Dahiya
University of California San Francisco, United States
Anyou Wang
DIFIBER LLC, United States
Michael Thompson
University of Toronto, Canada Cancer Research 2026 Speakers
Paulo Cesar De Morais
Catholic University of Brasilia, Brazil
Shilpa S Dhar
UT MD Anderson Cancer Center, United States
Eleni Petsalaki
University of Crete, Greece
Can Küçük
Dokuz Eylul University, TurkeySubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : Uncovering tumor-suppressive roles of histone modifiers in gastric cancer through spatial transcriptomics and epigenomics
Shilpa S Dhar, UT MD Anderson Cancer Center, United States
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : A case-based approach using IMPeTUs criteria in FDG PET/CT reporting of multiple myeloma
Mudalsha Ravina, All India Institute of Medical Sciences, India
Title : Updates on controversies surrounding the staging and management of newly diagnosed localized prostate cancer using prostate-specific membrane antigen (PSMA) positron emission tomography
Patricia Tai, University of Saskatchewan, Canada
Title : A pioneering, first-of-its-kind Canadian off-site program designed to reduce the burden on hospital staff and optimize the use of space
Patricia Tai, University of Saskatchewan, Canada